Genetic testing has 3 outcomes: confirmatory (identification of a known pathogenic mutation, clear cosegregation within phenotype in a family, or functional gene studies that validate pathogenicity), ...

To access our most recent research and articles on Covid-19 and Covid-19 vaccines, please visit the NEJM Coronavirus (Covid-19) page. To realize the potential of recently developed Covid-19 ...

From 2025 to 2035, residual current circuit breaker market is expected to flourish at a CAGR of 6.7%. By 2035, the market ...

The deaths have been registered amid a nationwide surge in COVID-19 cases. The number of active cases in the country passed the 2,700-mark on Saturday, with Delhi reporting the third-highest number of ...

Cartesian Therapeutics, Inc. has announced the enrollment of the first participant in its Phase 3 AURORA trial for Descartes-08, its lead cell therapy candidate aimed at treating myasthenia gravis ...

But the Knicks rallied on the Pacers' home court in Game 3 after a fourth-quarter surge from Karl-Anthony Towns. The Pacers responded by taking Game 4 at home, and the Knicks handily defeated ...

The cryptocurrency market is currently encountering a mild surge. Bitcoin at present is sitting at $108K ... However, as volatile as the market is at the moment, these 3 coins are poised to gain ...

The altcoin market is showing renewed strength despite a modest pullback in Bitcoin’s price. While BTC trades near $108,000—down nearly 1% from its all-time high of $111,970—several major altcoins are ...

CORPUS CHRISTI, Texas — TxDOT crews were in Aransas Pass on Wednesday conducting their annual hurricane surge wall drill ahead of the 2025 Atlantic hurricane season. The surge wall plays a vital ...

The regulatory filing states that enrollment in the global Phase 3 HAELO study of NTLA-2002 for hereditary angioedema is on track. The company expects to complete enrollment in the third ...

Topline data were announced from a phase 3 trial evaluating AD109 (aroxybutynin 2.5mg/atomoxetine 75mg) in participants with obstructive sleep apnea (OSA). AD109 is a once daily pill that consists of ...

Neuronata-R® holds Orphan Drug Designation from both the U.S. FDA (2018) and the EMA (2019). CorestemChemon completed a Phase 2 trial (NCT01363401) in 2014 and its Phase 3 trial (NCT04745299) in 2024; ...